ARCHIVES

Aranesp Improved Anemia In MDS In Phase II Trial

This article is from The Cancer Letter archive.

Vol. 28 No. 9 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

Itri Pays Fine, Agrees Not to Serve As Company Officer for Five Years

April 25, 2014

New Screening Tool Helps GP ID Hereditary BC Risk

October 27, 2006

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

Progress Toward Year 2000 Goal Slow, But NCAB Says It’s Too Early, Only Data Up To ’87 Available

January 12, 1990

Grants & Contracts: NCI Workshop Informs Historically Black Institutions About Funding Process

October 10, 1997

NCI Study Tests Donor T Cells Against Breast Cancer

August 29, 2003